Clinical Protocol and Data Management
临床方案和数据管理
基本信息
- 批准号:9755225
- 负责人:
- 金额:$ 9.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAmendmentAreaAwarenessCancer CenterCancer Center Support GrantCaringCatchment AreaChildClinicalClinical DataClinical ManagementClinical ProtocolsClinical ResearchClinical TrialsDataData Base ManagementData ReportingDevelopmentDiseaseEducationEnrollmentEnsureFrequenciesGuidelinesIndustryMalignant NeoplasmsMedical centerMedidataMissionMonitorMonitoring Clinical TrialsNCI Center for Cancer ResearchNational Clinical Trials NetworkNebraskaOffice ManagementPediatric Oncology GroupPhasePopulationPopulation SciencesProceduresProcessProtocols documentationRegulationReportingResearchResearch PersonnelResearch SupportResourcesReview CommitteeRural PopulationSafetySerious Adverse EventSiteSystemTimeTraining and EducationUniversitiesWomananticancer researchcancer carecancer clinical trialcancer therapydata managementimprovedinvestigator-initiated trialmembermetropolitanparticipant safetyprogramsprotocol developmentquality assurancerecruitresearch studyscreeningunderserved minority
项目摘要
Project Summary/Abstract: Clinical Protocol and Data Management (CPDM)
The Office for Cancer Clinical Research (OCCR), previously referred to as the Centralized Protocol Data
Management Unit (CPDMU), is the centralized office that supports clinical cancer research in the Fred and
Pamela Buffett Cancer Center (FPBCC) at the University of Nebraska Medical Center (UNMC). The OCCR
provides centralized support for investigator-initiated trials (IIT), NCI National Clinical Trials Network and
cooperative group trials (Main Member of Alliance, Children's Oncology Group, NRG) multi-institutional
consortium trials (BIG10 Cancer Consortium, ACCRU) and industry-sponsored studies. The mission of the
OCCR is to assist with the planning, development, conduct, quality assurance, monitoring and compliance of
with regulatory agency requirements for clinical trials involving cancer treatments and care, and to provide
regulatory support for cancer-related population science studies as well. The OCCR assures the highest
quality of research and adherence to relevant regulations by primary upfront coordination of the study and
ongoing review of research compliance. The OCCR is a resource within the FPBCC to provide investigators
support for all cancer-related clinical research. It is composed of disease-oriented teams (DOT's) that
coordinate study management activities (including screening subjects, coordination of treatment and care, and
collecting and recording study data), as well as the regulatory management teams responsible for submitting
and maintaining all regulatory documents and applications. The OCCR provides investigators with support and
study data management, as well as protocol development, monitoring for cooperative group studies, and
liaison with federal and industry sponsors and regulatory bodies. The OCCR provides resource support to the
FPBCC Scientific Review Committee (SRC), the Data Safety Monitoring Committee (DSMC), and the Audit
Committee (AC). The OCCR manages the clinical trials management system (CPDM database) which houses
protocol data necessary for planning, reporting and internal oversight, as well as eCRF development and study
data reporting in C3D and MediData RAVE. The FPBCC OCCR has been active in NCI initiatives regarding
the Clinical Trial Reporting Program (CTRP) and has been an early adopter of C3D and Medidata Rave.
项目摘要/摘要:临床方案和数据管理(CPDM)
癌症临床研究办公室(OCCR),以前称为集中协议数据
管理单位(CPDMU)是支持弗雷德和霍普金斯大学癌症临床研究的中央办公室
内布拉斯加州大学医学中心(UNMC)的帕梅拉·巴菲特癌症中心(FPBCC)。OCCR
为研究人员发起的试验(IIT)、NCI国家临床试验网络和
合作小组试验(联盟主要成员,儿童肿瘤学小组,NRG)多机构
财团试验(BIG10癌症协会,ACCRU)和行业赞助的研究。世界银行的使命是
OCCR将协助规划、开发、实施、质量保证、监测和遵守
符合监管机构对涉及癌症治疗和护理的临床试验的要求,并提供
对癌症相关人口科学研究的监管支持也是如此。OCCR确保最高
研究的质量和对相关法规的遵守,主要通过研究和前期协调
对研究合规性的持续审查。OCCR是FPBCC内的一个资源,为调查人员提供
支持所有与癌症相关的临床研究。它由以疾病为导向的团队(DOT)组成,
协调研究管理活动(包括筛选受试者、协调治疗和护理,以及
收集和记录研究数据),以及负责提交
并维护所有监管文件和申请。OCCR为调查人员提供支持和
研究数据管理,以及为合作小组研究制定方案和监测,以及
与联邦和行业赞助商及监管机构保持联系。OCCR为
FPBCC科学审查委员会(SRC)、数据安全监测委员会(DSMC)和审计
委员会(AC)。OCCR管理临床试验管理系统(CPDM数据库)
规划、报告和内部监督以及ECRF发展和研究所需的议定书数据
C3D和Medidata RAVE中的数据报告。FPBCC OCCR一直积极参与NCI的以下倡议
临床试验报告计划(CTRP)是C3D和Medidata Rave的早期采用者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Apar Kishor Ganti其他文献
Apar Kishor Ganti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Apar Kishor Ganti', 18)}}的其他基金
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
10618916 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
9883472 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer
MUC5AC在促进非小细胞肺癌中枢神经系统转移中的作用
- 批准号:
10454778 - 财政年份:2020
- 资助金额:
$ 9.36万 - 项目类别:
相似海外基金
Reserch on the theory and practice of Unconstitutional Constitutional Amendment
违宪修宪理论与实践研究
- 批准号:
22K01142 - 财政年份:2022
- 资助金额:
$ 9.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immobilizing vanadium with nano-oxide and biochar combined amendment and investigating the fate of amendment-vanadium complexes at varying geochemical environments of soils.
用纳米氧化物和生物炭组合改良剂固定钒,并研究改良剂-钒络合物在不同土壤地球化学环境下的命运。
- 批准号:
DDG-2022-00020 - 财政年份:2022
- 资助金额:
$ 9.36万 - 项目类别:
Discovery Development Grant
Biochar as a Soil Amendment for Revitalizing Stockpiled Soils and Facilitating Carbon Sequestration at an Oilsands Lease, Christina Lake, Alberta
生物炭作为土壤改良剂,可恢复阿尔伯塔省克里斯蒂娜湖油砂租地的储存土壤并促进碳封存
- 批准号:
561419-2020 - 财政年份:2022
- 资助金额:
$ 9.36万 - 项目类别:
Applied Research and Development Grants - Level 2
Policy framing and its legislative consequence: A comparative analysis of Copyright Act Amendment in Korea and Japan
政策框架及其立法后果:韩日著作权法修正案的比较分析
- 批准号:
22K01648 - 财政年份:2022
- 资助金额:
$ 9.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Efficient utilization of biochar for water remediation and soil amendment - towards a circular economy
有效利用生物炭进行水体修复和土壤改良——迈向循环经济
- 批准号:
2747765 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:
Studentship
Developing a New Sustainable Product: Wood Ash Recycling as Soil Amendment
开发新的可持续产品:木灰回收作为土壤改良剂
- 批准号:
570816-2021 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:
Applied Research and Development Grants - Level 1
Biochar as a Soil Amendment for Revitalizing Stockpiled Soils and Facilitating Carbon Sequestration at an Oilsands Lease, Christina Lake, Alberta
生物炭作为土壤改良剂,可恢复阿尔伯塔省克里斯蒂娜湖油砂租地的储存土壤并促进碳封存
- 批准号:
561419-2020 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:
Applied Research and Development Grants - Level 2
Rock dust from mine waste as a natural media amendment in forest reclamation and the production of high value agronomic and horticultural crops
矿山废料中的岩尘作为森林开垦和高价值农业和园艺作物生产中的天然介质改良剂
- 批准号:
531858-2018 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:
Collaborative Research and Development Grants
Efficient utilization of biochar for water remediation and soil amendment towards a circular economy
有效利用生物炭进行水修复和土壤改良,实现循环经济
- 批准号:
BB/W510361/1 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:
Training Grant
North Carolina Occupational Health Surveillance Program (Budget Amendment)
北卡罗来纳州职业健康监测计划(预算修正案)
- 批准号:
10464873 - 财政年份:2021
- 资助金额:
$ 9.36万 - 项目类别:














{{item.name}}会员




